600+ sources. One page. See who else covered it.
Vaderis Therapeutics’ bet that a type of treatment developed for cancers could work for a rare blood disorder is paying off. The 13-person Swiss startup raised $152 million in a Series B to run a ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
WHO Sierra Leone Second Quarter 2026 Results Newsletter sharkahm@who.int Tue, 11/08/2026 - 12:00 From strengthening maternal health services and disease prevention programmes to advancing emergency…
The startup is one of at least a few young companies zeroing in on the rare bleeding disorder, hereditary hemorrhagic telangiectasia, with a more precise AKT blocker.
[Liberian Observer] The Ministry of Health and its partners have concluded the 2026 National Health Review Conference with what health experts describe as one of the country's most consequential…
Experts are now supervising treatment, with acute nutritional deficiencies also detected among children
The Saudi embassy in Sudan has launched the Noor Saudi medical volunteer program at Makkah Hospital in Port Sudan, aiming to benefit thousands.
Olha Holubovska, infectious disease specialist and Doctor of Medical Sciences